ZURICH/FRANKFURT, Oct 23 — Roche on Monday said it will buy Telavant, a developer of a new treatment for inflammatory bowel diseases, for an initial US$7.1 billion from US biotech firm Roivant Holdings and Pfizer Inc.

By Danial Dzulkifly KUALA LUMPUR, Oct 20 – The Selangor International Business Summit (SIBS) 2023 has surpassed all expectations after recording a whopping RM2.9 billion in potential transaction value within two days, far exceeding its target of RM1.5 billion.  Selangor Menteri Besar Dato’...